Cabozantinib (free base)
Cabozantinib is the s -malate form of cabozantinib, an orally bioavailable small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Cabozantinib strongly binds and inhibits multiple RTKs, which may inhibit tumor growth and angiogenesis and ultimately lead to tumor regression.
| Supplier | Alfa Cytology |
|---|---|
| Product # | BC0478 |
| Pricing | 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, 500.0 mg, 1.0 g, 2.0 g, 5.0 g, inquire |